News
Technical Insight——Why Organoids Are Becoming a Critical Tool in Drug Discovery
For decades, preclinical research has relied heavily on two experimental systems: traditional cell cultures and animal models. Both have contributed…
Technical Insight——Why Targeted Protein Degradation Is Reshaping Drug Discovery
For decades, drug discovery has largely relied on inhibition. Whether targeting kinases, receptors, or enzymes, most therapeutic strategies have focused…
Technical Insight——Why Hyperuricemia Models Often Produce Unstable Results
Hyperuricemia (HUA) research has expanded far beyond gout alone. Elevated uric acid levels are now closely associated with chronic kidney…
Technical Insight——Selecting Appropriate Preclinical Lung Metastasis Models
Lung metastasis is one of the most common progression patterns observed across solid tumors including breast cancer, melanoma, colorectal cancer,…
Technical Insight——Ensuring Reliable Flow Cytometry Data: From Sample Preparation to Multi-Parameter Analysis
Overview Flow cytometry is widely used in preclinical research for multi-parameter cellular analysis, including immune profiling, cell cycle analysis, and…
Technical Insight——Ensuring Reliable ELISA Results: From Experimental Design to Data Quality Control
Overview ELISA is widely used for quantitative detection in preclinical and biomedical research. However, data reliability often depends less on…